Activities of telithromycin, erythromycin, fluoroquinolones, and doxycycline against Campylobacter strains isolated from Finnish subjects.
The in vitro susceptibilities of 478 Campylobacter jejuni and Campylobacter coli strains isolated from Finnish subjects during 2002 to 2004 were determined. Susceptibility to erythromycin remained high, and telithromycin did not offer any advantage over erythromycin. Reduced susceptibilities to fluoroquinolones and doxycycline were detected almost exclusively among isolates of foreign origin.
Department of Bacteriology and Immunology, Haartman Institute, P.O. Box 21, FIN-00014 University of Helsinki, Helsinki, Finland.
Daniela
D
Schönberg-Norio
Marja-Liisa
ML
Hänninen
Marja-Leena
ML
Katila
Suvi-Sirkku
SS
Kaukoranta
Markku
M
Koskela
Erkki
E
Eerola
Jaakko
J
Uksila
Sini
S
Pajarre
Hilpi
H
Rautelin
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002167:Campylobacter / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification; D004318:Doxycycline / Q000494:pharmacology*; D004917:Erythromycin / Q000494:pharmacology*; D005387:Finland / Q000453:epidemiology; D024841:Fluoroquinolones / Q000494:pharmacology*; D006801:Humans; D048628:Ketolides / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests
D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D048628:Ketolides; D004917:Erythromycin; C106791:telithromycin; D004318:Doxycycline